EDT Spectral Medical Inc.

TSX · CA · Healthcare · Diagnostics & Research · spectraldx.com

1.080CAD-6.90%Mkt Cap: 230.89M $P/E: —1d ago

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activi…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

IDEXX Laboratories, Inc.

$39.97BUSDP/E 35.6

MTD

Mettler-Toledo International Inc.

$30.73BUSDP/E 34.6

Labcorp Holdings Inc.

$25.30BUSDP/E 25.8

DGX

Quest Diagnostics Incorporated

$25.06BUSDP/E 24.1

Guardant Health, Inc.

Medpace Holdings, Inc.

$16.87BUSDP/E 35.5

ERF

Eurofins Scientific SE

$14.23BUSDP/E 26.6

CRL

Charles River Laboratories International, Inc.

$14.34BUSD

ICLR

ICON Public Limited Company

Key Statistics

Company

Market Cap230.89M USD

Enterprise Value265.41M USD

Revenue (TTM)1.87M USD

Gross Profit965.67K USD

Net Income (TTM)-34.73M USD

Revenue/Share0.0090 CAD

Last Price1.080 CAD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees29

CountryCA

SectorHealthcare

IndustryDiagnostics & Research

ISINCA8475771033

Valuation

P/E (Trailing)—

P/E (Forward)58.00

PEG—

EV/EBITDA-35.24

EV/Revenue141.86

P/S132.55

P/B-4.85

EPS (TTM)-0.12

EPS (Forward)0.02

52W Range

1.0308% of range1.650

52W High1.650 CAD

52W Low1.030 CAD

Profitability

Gross Margin54.30%

Oper. Margin-338.65%

EBITDA Margin0.00%

Profit Margin-1952.99%

ROE68.40%

ROA-781.84%

Growth

Revenue Growth-23.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF-6.94M USD

CapEx (TTM)142.01K USD

FCF Margin467.59%

FCF Yield3.79%

Net Debt17.43M USD

Net Debt/EBITDA-2.31

Balance Sheet

Debt/Equity-0.31

Current Ratio0.04

Quick Ratio0.02

Book Value/Sh-0.24 CAD

Cash/Share0.0030 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 CAD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div DateDec 19, 2011

Pay Date—

Analyst Consensus

Rating—

Target (Mean)3.150 CAD

Upside (mean)+191.7%

Target Range2.800 CAD – 3.500 CAD

2.800+191.7% to mean3.500

# Analysts2

Ownership

Shares Out.293.55M

Float288.11M

Insiders17.21%

Institutions12.39%

Short Interest

Short Ratio8.2d

Short % Out.0.10%

Shares Short301.83K

Short (prev mo.)311.76K

Technical

SMA 501.293 (-16.5%)

SMA 2001.343 (-19.6%)

Beta0.22

S&P 52W Chg16.45%

Avg Vol (30d)57.00K

Avg Vol (10d)28.12K

Technical Indicators

RSI (14)34.2

MACD-0.0503

MACD Signal-0.0483

MACD Hist.-0.0020

BB Upper1.319 CAD

BB Middle1.187 CAD

BB Lower1.056 CAD

BB Width22.17%

ATR (14)0.0639 CAD

Vol Ratio (20d)1.05x